New to The Street Signs Six-Part Media Series Featuring Medicus Pharma Ltd.

The comprehensive series is designed to elevate Medicus' visibility with institutional investors, analysts, and the broader healthcare and life sciences community.

Published on Feb. 10, 2026

Got story updates? Submit your updates here. ›

New to The Street, a nationally syndicated, long-form television and digital media platform, has signed a six-part media series with Medicus Pharma Ltd. (NASDAQ:MDCX), a precision guided biotech/life sciences company focused on advancing the clinical development program of novel and potentially disruptive therapeutics assets. The engagement will spotlight Medicus Pharma's clinical progress, management vision, and long-term growth opportunities, delivering consistent, high-quality exposure over the course of the engagement.

Why it matters

The collaboration reflects New to The Street's continued focus on delivering predictable, repeatable media exposure for public and private companies through long-form storytelling, national television distribution, and one of the most engaged digital financial audiences in the market. This series will help elevate Medicus Pharma's visibility with key stakeholders in the healthcare and life sciences community.

The details

The comprehensive six-part media series is designed to showcase Medicus Pharma's clinical progress, management vision, and long-term growth opportunities. The engagement will deliver consistent, high-quality exposure across linear television, digital, social, and investor-focused channels, creating a powerful narrative cadence that resonates with both Wall Street and Main Street.

  • The six-part media series with Medicus Pharma Ltd. was announced on February 10, 2026.

The players

Medicus Pharma Ltd.

A precision guided biotech/life sciences company focused on advancing novel and potentially disruptive select therapeutic assets through Phase 2 proof-of-concept and pursuing licensing or strategic partnerships with established pharmaceutical companies.

New to The Street

A long-running financial media platform producing in-depth interviews and branded content for innovative public and private companies. Broadcasting nationally as sponsored programming and supported by a global digital footprint, New to The Street delivers long-form storytelling, investor-focused content, and integrated media strategies across television, YouTube, and social platforms.

Vince Caruso

Founder and CEO of New to The Street.

Got photos? Submit your photos here. ›

What they’re saying

“Medicus Pharma represents the type of innovative, science-driven company that our platform is built to support. This engagement provides sustained visibility across linear television, digital, social, and investor-focused channels – creating a powerful narrative cadence that resonates with both Wall Street and Main Street.”

— Vince Caruso, Founder and CEO of New to The Street

The takeaway

This six-part media series showcases New to The Street's ability to deliver consistent, high-quality exposure for innovative biotech and life sciences companies like Medicus Pharma across multiple media channels. The collaboration reflects New to The Street's focus on elevating the visibility of public and private companies with key stakeholders in their respective industries.